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Edited by Hans-Dieter KlenkAbstract Coronavirus envelope (E) protein is a small integral
membrane protein with multi-functions in virion assembly, mor-
phogenesis and virus–host interaction. Diﬀerent coronavirus E
proteins share striking similarities in biochemical properties
and biological functions, but seem to adopt distinct membrane
topology. In this report, we study the membrane topology of
the SARS-CoV E protein by immunoﬂuorescent staining of cells
diﬀerentially permeabilized with detergents and proteinase K
protection assay. It was revealed that both the N- and C-termini
of the SARS-CoV E protein are exposed to the cytoplasmic side
of the membranes (NcytoCcyto). In contrast, parallel experiments
showed that the E protein from infectious bronchitis virus (IBV)
spanned the membranes once, with the N-terminus exposed lumi-
nally and the C-terminus exposed cytoplasmically (Nexo(lum)-
Ccyto). Intriguingly, a minor proportion of the SARS-CoV E
protein was found to be modiﬁed by N-linked glycosylation on
Asn 66 and inserted into the membranes once with the C-termi-
nus exposed to the luminal side. The presence of two distinct
membrane topologies of the SARS-CoV E protein may provide
a useful clue to the pathogenesis of SARS-CoV.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The acute respiratory syndrome coronavirus (SARS-CoV) is
an enveloped virus with a single strand, positive-sense RNA
genome of 29.7 kb in length. Similar to other coronaviruses,
its envelope typically contains three major structural proteins:
spike (S), membrane (M) and envelope (E), with functions
including recognition of target cells and fusion, interaction
with other viral components, and involvement in virion assem-
bly and budding.
All coronavirus E proteins are small integral membrane pro-
teins with a long hydrophobic stretch from 25 to 30 residues
[2,4,26]. They vary in size from 76 to 109 amino acids. The pro-
tein is associated with the ER and Golgi complex, and can be
translocated to the surface of the infected cells [4,16,23,26,27].
Functionally, coronavirus E protein plays a pivotal role in viral*Corresponding author. Fax: +65 67791117.
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doi:10.1016/j.febslet.2006.04.076morphogenesis, assembly and budding. Co-expression ofmouse
hepatitis virus (MHV) E and M was shown to result in the pro-
ductionof virus-like particles, roughly the same size and shape as
virions [18,31]. The same phenomena were also observed in
other coronaviruses, such as SARS-CoVand infectious bronchi-
tis virus (IBV) [5,9]. When the E protein was expressed in mam-
malian cells on its own, the E-containing vesicles can be
produced and released to the culture medium [5,19]. Further-
more, MHV and SARS-CoV E proteins were shown to induce
apoptosis [1,32]. More recently, the SARS-CoV E protein was
found to permeabilize bacterial cells as well as to form pores in
artiﬁcial membranes [14,15,31]. It was also reported that
MHV E protein could modify the membrane permeability in
both Escherchia coli and mammalian cells [18].
Despite the similarities in biochemical properties and biolog-
ical functions, the E protein from diﬀerent coronaviruses
shares very low homology in the primary amino acid sequence
[18]. Another striking feature is that diﬀerent coronavirus E
proteins assume distinct membrane topologies. Based on cell
surface staining with a C-terminus-speciﬁc antibody, transmis-
sible gastroenteritis virus (TGEV) E protein was demonstrated
to have a CexoNcyto membrane topology [8]. The IBV E protein
is accessible to a C-terminus-speciﬁc antibody in the presence
of either digitonin or Triton X-100 but is accessible to an N-
terminus-speciﬁc antibody only in the presence of Triton X-
100, suggesting that IBV E protein may possess an NexoCcyto
topology [4]. Immunoﬂuorescence analysis of cells expressing
MHV E protein demonstrated that its transmembrane domain
spans the lipid bilayer twice, indicating that both the N- and C-
terminal regions are exposed to the cytoplasm (NcytoCcyto)
[20,26]. The putative transmembrane domain of SARS-CoV
E protein has been reported to adopt a highly unusual topol-
ogy, consisting of a very short transmembrane helical hairpin
[2], with Phe23 as the center of inversion of the hairpin. This
residue was suggested to be located at the center of the bilayer
[2], although a more recent report places this residue adjacent
to the polar head groups of the lipids [11]. However, in silico
[28] and in vitro NMR and infrared dichroic data (unpublished
results) are in contrast with this model and are consistent with
a normal transmembrane helix. In addition, the membrane ori-
entation of the protein is yet to be determined.
In this report, the membrane topology of SARS-CoV E pro-
tein was determined by immunoﬂuorescent staining of cells dif-
ferentially permeabilized with detergents and by limited
proteinase K digestion of microsomal membranes. These stud-
ies have revealed that both the N- and C-terminal regions ofblished by Elsevier B.V. All rights reserved.
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a minor proportion of the protein is found to be posttransla-
tionally modiﬁed by N-linked glycosylation on the asparagine
66 residue. It suggests that a certain proportion of the protein
may also adopt either an NcytoCexo or NexoCexo topology. This
is the ﬁrst coronavirus E protein with two distinct membrane
topologies.2. Material and methods
2.1. Polymerase chain reaction and site-directed mutagenesis
Ampliﬁcation of respective template DNAs with appropriate prim-
ers was performed with Pfu DNA polymerase (Strategene) with
2 mM MgCl2. The PCR conditions were 35 cycles of 94 C for 45 s,
46–58 C for 45 s, and 72 C for 30 s. The annealing temperature
and extension time were subjected to adjustments according to the
melting temperatures of the primers used and the lengths of the PCR
fragments synthesized.
Site-directed mutagenesis was carried out with two rounds of PCR
and two pairs of primers.
2.2. Transient expression of SARS-CoV sequence in mammalian cells
HeLa cells were grown at 37 C in 5% CO2 and maintained in Glas-
gow’s modiﬁed Eagle’s medium supplemented with 10% fetal calf ser-
um. SARS-CoV E and mutants were placed under the control of a T7
promoter and transiently expressed in mammalian cells using a vac-
cinia virus/T7 expression system described by Fuerst et al. [7]. Brieﬂy,
60–80% conﬂuent monolayers of HeLa cells grown on dishes (Falcon)
were infected with 10 plaque-forming units/cell of a recombinant vac-
cinia virus (vTF7-3) that expresses T7 RNA polymerase. Two hours
later, cells were transfected with plasmid DNA mixed with Eﬀectene
according to the instructions of the manufacturer (Qiagen). Cells were
harvested at 12–24 h post-transfection.
2.3. Western blot analysis
Total proteins extracted from HeLa cells were lysed with 2· SDS
loading buﬀer in the presence of 200 mM DTT plus 10 mM of iodo-
acetamide and subjected to SDS–PAGE. Proteins were transferred to
PVDF membrane (Stratagene) and blocked overnight at 4 C in
blocking buﬀer containing 5% fat free milk powder in PBST buﬀer
pH 7.5 (80 mM Na2HPO4,20 mM NaH2PO4,100 mM NaCl, 0.1%
Tween 20). The membrane was incubated with 1:2000 diluted pri-
mary antibodies in blocking buﬀer for 2 h at room temperature. After
washing three times with PBST, the membrane was incubated with
1:2000 diluted anti-mouse or anti-rabbit IgG antibodies conjugated
with horseradish peroxidase (DAKO) in blocking buﬀer for 1 h at
room temperature. After washing for three times with PBST, the
polypeptides were detected with a chemiluminescence detection kit
(ECL, Amersham Biosciences) according to the instructions of the
manufacturer.
2.4. Indirect immunoﬂuorescence
HeLa cells expressing Flag-tagged SARS-CoV or IBV E protein
were ﬁxed with 4% paraformaldehyde for 10 min at 16 h post-transfec-
tion, washed three times with 1· PBS, permeabilized with 0.2% Triton
X-100 for 10 min at room temperature, and washed three times with 1·
PBS. Monoclonal anti-Flag antibody was used to detect E protein and
mutants. To selectively permeabilize the plasma membrane, HeLa cells
were ﬁxed with 4% paraformaldehyde for 10 min and permeabilized
with 5 lg of digitonin per ml for 5 min at room temperature. Staining
was as described above. Images were collected with a META 510 con-
focal laser-scanning microscope (Zeiss).
2.5. Glycosylation study of E protein
HeLa cells expressing E protein were treated with glycoprotein dena-
turing buﬀer (0.5% SDS and 1% b-mercaptoethanol) at 100 C for
10 min. The denatured proteins were incubated with 1 ll glycosidase
PNGaseF (Research Biolabs) in the reaction buﬀer (50 mM sodium
phosphate, pH 7.5) supplemented with 1% NP40 at 37 C for 1 h.
The deglycosylated proteins were analyzed by western blot.2.6. Subcellular fractionation
HeLa cells were resuspended in hypotonic buﬀer (1 mM Tris–HCl,
pH 7.4, 0.1 mM EDTA, 15 mM NaCl) containing 2 lg of leupeptin
per ml and 0.4 mM phenylmethylsulfonyl ﬂuoride (PMSF) and broken
by 20 strokes with a Dounce cell homogenizer. Cell debris and nuclei
were removed by centrifugation at 1500 · g for 10 min at 4 C. The
cytosol fraction and membrane fraction (postnuclear fraction) were
separated by ultracentrifugation through a 6% sucrose cushion at
150000 · g for 30 min at 4 C. Membrane pellets were resuspended
in hypotonic buﬀer, treated with 1% Triton X-100, 100 mM Na2CO3
or 1 M KCl for 30 min, and further fractionated into supernatant (S)
and pellet (P) fractions by ultracentrifugation at 150000 · g for
30 min at 4 C.
2.7. Proteinase K protection assay
HeLa cells grown in 60 mm dishes were transfected with SARS-CoV
E and IBV E tagged with the Flag epitope at either N- or C-terminus,
respectively, by using the vaccinia/T7 virus (vTF7-3) system. After
incubation for 18 h, the cells were washed twice with ice-cold PBS,
scraped oﬀ the dish, and homogenized with 20 strokes in a tight-ﬁtting
Dounce homogenizer. Nuclei were removed by centrifugation at 1200
rpm for 15 min at 4 C. Individual samples with the tagged SARS-CoV
E or IBV E proteins were split into three microcentrifuge tubes. One
tube was taken as control, the remaining two tubes in the absence or
presence of 1% Triton X-100 were subjected to 20 lg/ml proteinase
K digestion for 40 min on ice. The reaction was stopped by adding
4 mM PMSF. The samples were incubated at 100 C for 15 min in
the Laemmli sample buﬀer and then analyzed on SDS–PAGE.
2.8. Metabolic radiolabeling, immunoprecipitation and SDS–PAGE
HeLa cells in 100 mm dish were transfected with appropriate plasmid
DNA, treated with diﬀerent concentrations of hygromycin B (Sigma)
for 30 min in methionine/cysteine free medium at 12 h post-transfec-
tion, and 25 lCi/ml of [35S] methionine/cysteine (Amersham) were
added to the culture medium. The cells were incubated at 37 C for
3 h in the presence or absence of hygromycin B, harvested and lysed
in RIPA buﬀer containing 1.0 mM PMSF and 10 lg/ml each aprotinin
and leupeptin (Roche Applied Science). The cell extracts were clariﬁed
at 13000 rpm at 4 C for 10 min, and the proteins were immunoprecip-
itated with appropriate antibodies for 1 h at 4 C, incubated with 20 ll
of protein A–agarose overnight at 4 C, and washed three times with
RIPA buﬀer. The proteins were analyzed by 15% SDS–PAGE.
2.9. Construction of plasmids
Plasmid Flag-SARS E, which covers the SARS-CoV E sequence,
was constructed by cloning an EcoRV-/EcoRI-digested PCR fragment
into EcoRV-/EcoRI-digested pKT0-Flag. The PCR fragment was gen-
erated using primers 5 0-GCAAGATATCCTACTCATTCGTTTCGG
AA-3 0 and 5 0-CCGGAATTCTTAGACCAGAAGATCAG-3 0. Plas-
mid SARS E-Flag was created by cloning a BglII-/EcoRI-digested
PCR fragment into BglII-/EcoRI-digested pKT0. The PCR fragment
was generated using primers 5 0-TGGAAGATCTCCACCATGTACT-
CATTCGTT TCGGAA-3 0 and 5 0-CGGAATTCTTACTTGT-
CATCGTCGTCCTTGTAATCGACCAGAAG ATCAGGAA-3 0.
Plasmid Flag-IBV E was generated by cloning an EcoRV-/EcoRI-di-
gested PCR fragment into EcoRV-/EcoRI-digested pKT0-Flag. The
two primers used to generate the PCR fragment are 5 0-GCAAGA-
TATCCAATTTATTGAATAAGTCG-30 and 5 0-CCGGAATTC
TCA AGAG TACAATTTGTC-30. Plasmid IBV E-Flag was created
by cloning a BglII-/EcoRI-digested PCR fragment into BglII-/EcoRI-
digested pKT0. The PCR fragment was generated using primers
5 0-TGGAAGATCTCCACCATGAATTTATTGAATAA-3 0 and 5 0-
CCGGAATTCTCACTTGTCA TCGTCGTCCTTGTAATCAGAG-
TACAATTTGTCTCG-30. Plasmid pKT-SARS E was constructed
by cloning a BglII-/EcoRI-digested PCR fragment into BglII-/EcoRI-
digested pKT0. The PCR fragment was generated using primers 5 0-
TGGAAGATCTCCACCAT GTACTCATTCGTTTCGGAA-3 0 and
5 0-CCGGAATTCTTAGACCAGAAGATCAG-3 0. Plasmid pKT-
IBV E was constructed by cloning a BglII-/EcoRI-digested PCR frag-
ment into BglII-/EcoRI-digested pKT0. The PCR fragment was gener-
ated using primers 5 0-TGGAAGAT CTCCACCATGAATTTATT
GAATAA-3 0 and 5 0-CCGGAATTCTCAAGAGTACAATTTG TC-
3 0. The underlined nucleotides represent the restriction sites introduced
into each primer.
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rounds of PCR. The PCR ampliﬁed fragments were cloned into
EcoRV- and EcoRI-digested pFlag. All plasmids and the introduced
mutations were conﬁrmed by automated DNA sequencing.3. Results
3.1. Prediction of the hydrophobicity and membrane topology of
SARS-CoV E protein
The hydrophobicity of the SARS-CoV E protein is shown as
a Kyte–Doolittle hydropathy plot in Fig. 1B. The protein is
largely hydrophobic in the region from amino acids 9 to 59.
In both N- and C-terminal regions, some hydrophilic amino
acid stretches were found.
Three computer programs, i.e., TMHMM [13], HMMTOP
[29], and MEMSAT [10], were used to predict the membrane
topology of the SARS-CoV E protein. All three programs pre-
dicted that SARS-CoV E protein contains one transmembrane
domain. Both TMHMM and MEMSAT predicted that SARS-
CoV E protein may assume an NcytoCexo topology, whereas
HMMTOP indicated that SARS-CoV E protein may adopt a
CcytoNexo topology.
3.2. Analysis of the membrane topology of SARS-CoV E protein
by immunoﬂuorescence microscopy
To test these predictions and to experimentally determine
the membrane topology of the SARS-CoV E protein, both
SARS-CoV and IBV E proteins were tagged with Flag at N-
and C-termini, respectively, and expressed in HeLa cells. Cells
were then permeabilized with either 0.5% Triton X-100 or 5 lg/
ml digitonin, and the expression of the Flag-tagged E protein
was detected by indirect immunoﬂuorescent staining using
anti-Flag monoclonal antibody. Treatment of cells with digito-
nin at low concentrations selectively permeabilizes the plasma
membrane but leaves the intracellular membranes intact, while
Triton X-100 treatment permeabilizes both plasma and intra-H
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Fig. 1. Diagram of wild type and mutant SARS-CoV E constructs, and hydro
wild type and mutant SARS-CoV E protein. The amino acid sequence of
residues and the two potential glycosylation sites are indicated in bold. Also s
(B) The hydropathy proﬁle of SARS-CoV E protein determined by Kyte and
character of this protein.cellular membranes [25]. If the Flag tag is exposed to the cyto-
plasmic side, the epitope can be recognized by anti-Flag
antibody after digitonin treatment. On the other hand, if the
Flag tag is exposed luminally, the epitope cannot be recognized
by the anti-Flag antibody after digitonin treatment. It can only
be recognized after Triton X-100 treatment.
As shown in Fig. 2, clear detection of the N- and C-termi-
nally tagged SARS-CoV E protein at perinuclear regions was
obtained in HeLa cells permeabilized with either 0.5% Triton
X-100 or 5 lg/ml digitonin (Fig. 2), suggesting that both N-
and C-termini of the protein may be located in the cytoplasmic
side. However, in cells expressing the N-terminally tagged IBV
E protein, expression of the protein was observed in cells per-
meabilized with 0.5% Triton X-100 only (Fig. 2). No detection
of the protein expression in cells permeabilized with 5 lg/ml
digitonin was obtained (Fig. 2). It is also noted that no signif-
icant diﬀerence in the staining intensity was observed between
cells treated with digitonin and Triton X-100. In cells express-
ing the C-terminally tagged IBV E protein, the protein was de-
tected in cells permeabilized under either condition (Fig. 2).
These results are consistent with the topology of IBV E protein
established before [4], and justify the experimental conditions
used. As a control, PDI, a host protein residing in the ER lu-
men, was detected in cells permeabilized with 0.5% Triton X-
100, but was not detected in cells permeabilized with 5 lg/ml
digitonin (Fig. 2), conﬁrming that the ER membrane was still
intact after treatment with digitonin (Fig. 2). Taken together,
these results indicate that both the N- and C-termini of the
SARS-CoV E protein may be located in the cytoplasmic side
of the cell, whereas IBV E protein adopts an NexoCcyto topol-
ogy.
3.3. Analysis of the membrane topology of SARS-CoV E protein
by diﬀerential permeabilization of the plasma membrane and
limited proteinase K treatment
The topology of SARS-CoV E protein on cellular mem-
branes was further analyzed by limited proteinase K digestionlot Kyte-Doolittle (window size=7)
phathicity score of SARS-CoV E protein. (A) Amino acid sequences of
the putative transmembrane domain is underlined, the three cysteine
hown are the mutations introduced into each of the mutant constructs.
Doolittle with a 7-residue window. It displays the highly hydrophobic
Fig. 2. Cytoplasmic exposure of the Flag epitope tagged at the N- and C-terminus of the SARS-CoV E protein and the C-terminus of the IBV E
protein. HeLa cells expressing Flag-SARS E, SARS E-Flag, Flag-IBV E and IBV E-Flag, respectively, were permeabilized using either 5 lg/ml
digitonin or 0.5% Triton X-100 and immunostained with anti-Flag antibody as the primary antibody and TRITC-conjugated anti-mouse IgG
antibody as the secondary antibody. Untransfected HeLa cells were treated with digitonin or Triton X-100 and immunostained with anti-PDI
antibody and TRITC-labeled anti-rabbit IgG secondary antibody.
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N- or C-terminally tagged E protein. Digestion with the non-
speciﬁc proteinase K would degrade proteins (or a portion of
the protein) protruding from the exterior face of the micro-
somal membranes, while proteins (or a portion of the protein)
orientated towards the lumen are protected. For this purpose,
HeLa cells expressing the Flag-tagged SARS-CoV E protein at
either N- or C-terminus were broken by homogenization, and
the membrane fraction was collected. The membrane fraction
was then divided into three aliquots: one was treated with both
1% Triton X-100 and 20 lg/ml proteinase K, one treated with
20 lg/ml proteinase K only, and one without any treatment.
The total proteins were then separated by SDS–PAGE and
analyzed by Western blot with anti-Flag antibody. As shown
in Fig. 3, eﬃcient detection of both N- and C-terminally
tagged SARS-CoV E protein was obtained from the untreated
membrane fraction (Fig. 3, lanes 1 and 4). Upon treatment of
the membrane fraction with 20 lg/ml proteinase K in the pres-
ence of 1% Triton X-100, no detection of the SARS-CoV Eprotein was observed from cells expressing either the N- or
C-terminally tagged E protein (Fig. 3, lanes 3 and 6), demon-
strating that treatment with proteinase K led to the removal of
the Flag tag from either terminus of the SARS-CoV E protein.
Similar results were observed after treatment of the membrane
fraction with 20 lg/ml proteinase K in the absence of 1% Tri-
ton X-100 (Fig. 3, lanes 2 and 5). However, prolonged expo-
sure of the same gel showed detection of minor amounts of
the E protein in the same fractions (data not shown).
In cells expressing the N- and C-terminally tagged IBV E
protein, the protein was clearly detected in the membrane frac-
tion without treatment with Triton X-100 and proteinase K
(Fig. 3, lanes 7 and 10). Treatment of the membrane fraction
with 20 lg/ml proteinase K resulted in the detection of a frag-
ment of approximately 10 kDa representing the N-terminal re-
gion of the IBV E protein (Fig. 3, lane 8). Upon treatment of
the membrane fraction with 1% Triton X-100 and 20 lg/ml
proteinase K, the IBV E protein was no longer detected
(Fig. 3, lane 9). In cells expressing the C-terminally tagged
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Fig. 3. Limited proteinase K digestion of microsomal membranes
prepared from cells expressing the SARS-CoV and IBV E protein
tagged with the Flag epitope at the N- and C-termini, respectively.
Intact microsomes were isolated from cells expressing Flag-SARS E,
SARS E-Flag, Flag-IBV E and IBV E-Flag, and subjected to digestion
by proteinase K in the absence (lanes 2, 5, 8, 11) or presence (lanes 3, 6,
9, 12) of Triton X-100. The proteinase K-treated samples were
separated on SDS–17.5% polyacrylamide gel and analyzed by Western
blot. PDI (an ER luminal protein) was detected by anti-PDI antibody
(Santa Cruz), and b-tubulin (a cytosolic protein) was detected by anti-
b-tubulin antibody (Santa Cruz). Numbers on the left indicate
molecular masses in kilodaltons.
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the membrane fraction with proteinase K in the presence or
absence of Triton X-100 (Fig. 3, lanes 10–12). Consistent with
the immunoﬂuorescence data, these results reinforce the con-
clusion that the N-terminus of the IBV E protein was located
in the lumen of the ER and the Golgi apparatus.
As an internal control for the integrity of microsomal mem-
branes after limited proteolytic digestion, the detection of PDI
was included in the experiment. As shown in Fig. 3, the full-
length PDI was detected in the membrane fraction before
and after treatment with 20 lg/ml proteinase K in the absence
of 1% Triton X-100 (lanes 1, 2, 4, 5, 7, 8, 10 and 11). In addi-
tion, a shorter form of the protein was also detected in the
membrane fraction after treatment with 20 lg/ml proteinase
K in the absence of 1% Triton X-100 (lanes 2, 5, 8 and 11).
In the presence of 1% Triton X-100, treatment of the mem-
brane fraction with proteinase K showed that no full-length
PDI was detected (Fig. 3, lanes 3, 6, 9 and 12). However, the
shorter form of PDI was still detected (Fig. 3, lanes 3, 6, 9
and 12), suggesting that it may represent a proteinase K-resis-
tant fragment of PDI. The fact that the shorter form of PDI
was detected in the membrane fraction after treatment with
20 lg/ml proteinase K in the absence of 1% Triton X-100 sug-
gests that the procedure used to prepare the membrane frac-
tion may result in partial disruption of the microsomes. In
the same experiment, b-tubulin was also included as an inter-
nal control for the degradation of cytosolic proteins. The pro-
tein was degraded by the treatment with 20 lg/ml proteinase K
in the presence or absence of Triton X-100 (Fig. 3). Together
with the immunoﬂuorescence studies, these results conﬁrm
that both the N-terminus and C-terminus of SARS-CoV E
are cytosolic with an orientation of NcytoCcyto.3.4. Glycosylation of SARS-CoV E protein
Examination of the SARS-CoV E protein sequence
showed the presence of two potential N-linked glycosylation
sites on asparagine 48 (N48) and 66 (N66) (Fig. 1A). If the
protein adopted a sole NcytoCcyto topology, glycosylation at
the two positions would not occur. However, multiple bands
were usually detected when the protein was expressed in dif-
ferent systems, suggesting that it may undergo posttransla-
tional modiﬁcations. To address the possibility that the
protein may be modiﬁed by N-linked glycosylation, muta-
tions were introduced into the E protein to change the pre-
dicted N-linked glycosylation sites from asparagine to
aspartic acid. Two mutants, N48-D and N66-D, were gener-
ated and expressed (Fig. 1A). Western blot analysis of cells
expressing wild type and the N48-D mutant showed the
detection of three bands on an SDS–17.5% polyacrylamide
gel (Fig. 4A, lanes 1 and 2). These may represent three iso-
forms of the E protein. In cells expressing the N66-D mu-
tant, only two bands were detected; the most slowly
migrating species of the three isoforms was not observed
(Fig. 4A, lane 3).
To analyze further the N-linked glycosylation of the E pro-
tein, cells expressing wild type (Fig. 5B, lanes 1 and 2) and mu-
tant E (Fig. 4B, lanes 3–6) were lysed. The total cell lysates
were ﬁrst treated with the N-linked glycosidase PNGaseF,
and analyzed by Western blot with anti-E polyclonal antibod-
ies. In cells expressing wild type and the N48-D mutant E pro-
tein, the protein was separated into two major bands in the gel
system used (Fig. 4B, lanes 1 and 3). Treatment of the same to-
tal cell lysates led to the removal of the upper band (Fig. 4B,
lanes 2 and 4), conﬁrming that it represents the glycosylated
form of the protein. In this gel system, the two unglycosylated
isoforms of wild type SARS-CoV E protein were not well sep-
arated, so three major bands were detected with Flag-SARS E
but only two major bands detected with wild type SARS-CoV
E. In addition, a minor species of approximately 20 kDa, rep-
resenting the dimeric form of the protein, was observed in cells
expressing the two constructs (Fig. 4B, lanes 1–4). In cells
expressing the N66-D mutant, the glycosylated form was not
detected either before or after treatment with PNGaseF
(Fig. 4B, lanes 5 and 6). Interestingly, in cells expressing this
mutant E protein, more dimeric form and a species represent-
ing trimers of the E protein were detected (Fig. 4B, lanes 5 and
6). It suggests that this mutant E protein tends to form multi-
mers or aggregates. As a control, cells expressing IBV E pro-
tein were treated with the same glycosidase. The protein was
detected as a single band in total cell lysates with or without
PNGaseF treatment (Fig. 4B, lanes 7 and 8). In cells express-
ing the Flag-tagged E protein, this treatment resulted in the
disappearance of the most slowly migrating species of the three
isoforms (Fig. 4B, lanes 9 and 10), further conﬁrming that it is
the glycosylated form of the E protein. It was noted that the
pattern of the Flag-tagged E protein present in this ﬁgure
was diﬀerent from that in Fig. 3. This is because that much
more materials were loaded and prolonged electrophoresis of
the gel was applied in order to separate well and to detect
clearly the minor glycosylated form of the protein. These re-
sults demonstrate that a minor proportion of the SARS-CoV
E protein is modiﬁed by N-linked glycosylation and the N66
residue is the site for this modiﬁcation. More importantly, it
suggests that this portion of the SARS-CoV E protein would
assume a diﬀerent membrane topology from the majority of
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by SDS–PAGE and analyzed by Western blot using the anti-Flag antibody. Numbers on the left indicate molecular masses in kilodaltons. (B) Total
cell lysates prepared from HeLa cells expressing wild type SARS-CoV E (lanes 1 and 2), N48-D (lanes 3 and 4), N66-D (lanes 5 and 6), wild type IBV
E (lanes 7 and 8) and the Flag-tagged SARS-CoV E (lanes 9 and 10) were treated either with (lanes 2, 4, 6, 8 and 10) or without (lanes 1, 3, 5, 7, and 9)
PNGase F. Polypeptides were separated by SDS–PAGE and analyzed by Western blot using anti-SARS-CoV E antibodies (lanes 1–6), anti-IBV E
(lanes 7 and 8) or anti-Flag (lanes 9 and 10). Numbers on the left indicate molecular masses in kilodaltons. (C) Subcellular localization of the Flag-
tagged wild type SARS-CoV E, N48-D and N66-D. BHK cells expressing the Flag-tagged wild type and mutant E protein were stained with anti-Flag
antibodies at 12 h posttransfection after permeabilizing with 0.2% Triton X-100. (D) Entry of hygromycin B into HeLa cells expressing wild type and
mutant E proteins. HeLa cells expressing N48-D (lanes 1–3) and N66-D (lanes 4–6), respectively, were treated with 0, 0.5 and 1 mM of hygromycin B
for 30 min at 12 h posttransfection, and radiolabelled with [35S] methionine–cysteine for 3 h. Cell lysates were prepared and the expression of E
protein was detected by immunoprecipitation with anti-Flag antibody under mild washing conditions. SARS-CoV N protein was co-expressed with
wild type and mutant E protein, and the expression of N protein was detected by immunoprecipitation with polyclonal anti-N antibodies.
Polypeptides were separated by SDS–PAGE and visualized by autoradiography. Numbers on the left indicate molecular masses in kilodaltons.
Q. Yuan et al. / FEBS Letters 580 (2006) 3192–3200 3197the E protein, i.e., the C-terminal region of the protein would
be located in the lumen of the ER and the Golgi apparatus.
The eﬀects of these mutations on the subcellular localization
of E protein were then analyzed. As shown in Fig. 4C, expres-
sion of the Flag-tagged SARS-CoV E protein in BHK cells sta-
bly expressing the T7 RNA polymerase [3] showed that the
protein mainly located in the perinuclear region. The two mu-
tant proteins also displayed very similar localization patterns
(Fig. 4C). These results demonstrated that mutation of the gly-
cosylation site of the protein does not aﬀect the membrane
association and subcellular localization patterns of the protein.
As the N66-D mutant tends to form multimers or aggre-
gates, it would be interesting to test if this mutation could af-
fect the membrane-permeabilizing activity of the SARS-CoV E
protein. For this purpose, the Flag-tagged constructs were ex-
pressed in HeLa cells. At 12 h post-transfection, cells were
treated with two diﬀerent concentrations of hygromycin B
for 30 min, and then radiolabeled with [35S] methionine–cys-
teine for 3 h. Cell extracts were prepared and the expressionof E protein was detected by immunoprecipitation with anti-
Flag antibody. As shown in Fig. 4D, this mutation did not
obviously aﬀect the membrane-permeabilizing activity of the
E protein. A very similar degree of inhibition of protein syn-
thesis was observed in cells expressing both N-48-D and N-
66-D constructs (Fig. 4D).
3.5. Cell surface expression of the SARS-CoV E protein
Immunoﬂuorescent staining of cells expressing the Flag-
tagged SARS-CoV E protein at either N- or C-terminus was
then carried out to test if the E protein translocated to the cell
surface could be accessed by the antibody. As shown in Fig. 5,
immunoﬂuorescent staining of HeLa cells expressing the N-
terminally Flag-tagged IBV E using anti-Flag antibody exhibit
typical cell surface staining. In cells expressing SARS-CoV E
protein with the Flag epitope tagged at either N- or C-termi-
nus, no cell with obvious positive staining was detected
(Fig. 5). However, cells with a few ﬂuorescent dots on the sur-
face were consistently observed (Fig. 5).
Fig. 5. Surface staining of HeLa cells expressing the SARS-CoV E
protein with Flag tagged at the N- and C-terminus, respectively, and
IBV E protein with the Flag tagged at the N-terminus. HeLa cells
expressing Flag-SARS E, SARS E-Flag and Flag-IBV E, respectively,
were immunostained with anti-Flag antibody as the primary antibody
and TRITC-conjugated anti-mouse IgG antibody as the secondary
antibody.
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Coronaviruses encode a small integral membrane protein
that is associated with the viral envelope and plays important
functions in virion assembly and morphogenesis [19,30]. Re-
cently, the E protein from SARS-CoV and MHV was shown
to enhance the membrane permeability of bacterial and mam-
malian cells to small molecules [14,15,18]. SARS-CoV E pro-
tein contains a putative long transmembrane domain of 29
amino acid residues. Based on the distribution of the charged
amino acids ﬂanking the transmembrane domain and the re-
cent observation that the E protein is palmitoylated on allN
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Fig. 6. Proposed membrane topologies of the unglycosylated form of the SA
CoV E protein (B). N and C represent the N- and C-termini of the proteins, r
C-terminal ends are located in the same side of the membrane are indicated b
is shown at the C terminus of the two proposed forms by stars.three cysteine residues [15], the protein may insert into the
ER and Golgi membranes with an Nexo(lum)Ccyto orientation.
In vitro results reported by Arbely et al. suggest that the trans-
membrane domain of SARS-CoV may adopt a highly unusual
topology, consisting of a short transmembrane helical hairpin
that forms an inversion about a previously unidentiﬁed pseu-
do-centre of symmetry [2], although this is in contrast with
simulation results based on phylogenetic data [28]. In the pres-
ent study, the membrane topology of the SARS-CoV E protein
is systematically studied with N- and C-terminally Flag-tagged
SARS-CoV E protein. As the Flag tag does not aﬀect the re-
lease of E-containing vesicles and virus-like particles (data
not shown), and the permeabilizing activity of the protein, it
is assumed that the Flag-tagged E protein is functionally ac-
tive. Immunoﬂuorescent staining of cells diﬀerentially perme-
abilized with detergents and proteinase K protection assay
revealed that both the N- and C-termini of the SARS-CoV E
protein are exposed to the cytoplasmic side of the membranes
(NcytoCcyto) (see Fig. 6A). Two potential forms are proposed
(Fig. 6A, forms (1) and (2)). Based on Arbely et al. [2], the
SARS-CoV E protein may assume the form (1) topology.
However, we cannot rule out the possibility that the protein
may cross the membrane twice and assume the form (2) topol-
ogy, based on our biophysical and molecular simulation data
[28]. Consistent with previous studies, parallel experimental
data presented in this study demonstrated that the IBV E
protein spans the membranes once with the N-terminus
exposed luminally and the C-terminus exposed cytoplasmically
(Nexo(lum)Ccyto) (see Fig. 6A).
Interestingly, a small proportion of the SARS-CoV E pro-
tein was shown to be modiﬁed by N-linked glycosylation on
the asparagine 66 residue. Glycosylation of the C-terminal re-
gion of the E protein was an unexpected ﬁnding, since no pro-
teinase K-protected fragment was detected in the limited
proteinase K assay. Nevertheless, the detection of the N-linked
glycosylation at the C-terminal region and the ineﬃcient syn-
thesis of the glycosylated form suggest that the SARS-CoV
E protein may have an alternative membrane topology. Two
possible models for this alternative membrane topology of
the SARS-CoV E protein were proposed (Fig. 6B). In the
ﬁrst case, the protein may span the membranes once with an
NcytoCexo(lum) orientation (Fig. 6B). Alternatively, both N- and
C-termini may be exposed to the luminal side of the mem-
branes (Nexo(lum)Cexo(lum)) (Fig. 6B). Once again, two potential
forms are proposed (Fig. 6B, form (1) and (2)). At present, wenoitalysocylg deknil-N=
N
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C
N
B
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)2(
RS-CoV E (A), the IBV E (A), and the glycosylated form of the SARS-
espectively. The two potential forms of SARS-E when both the N- and
y (1) and (2). The Asn-linked high mannose carbohydrate modiﬁcation
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ogy for this portion of the E protein, as neither the full-length
nor a shorter form of the protein was detected in the limited
proteinase K assay probably due to the reason that only a very
small proportion of protein assumes this topology.
It is therefore established that the majority of the SARS-
CoV E protein is inserted into cellular membranes with an
NcytoCcyto topology, but a small proportion of the protein is
modiﬁed by N-linked glycosylation and inserted into the mem-
branes with the C-terminus exposed to the luminal side. There
are a few examples of viral proteins that adopt more than one
membrane topology. These include the transmissible gastroen-
teritis coronavirus membrane protein [6], the fusion protein F
from the Newcastle disease virus [21] and the adenovirus E3, a
6.7K protein [22]. As coronavirus E protein including SARS-
CoV E protein is a multi-functional protein, it would be
important to establish whether diﬀerent topological forms
are responsible for a distinct function. The SARS-CoV E
protein was found to interact with Bcl-xL [32]. As this interac-
tion was mediated by the C-terminal BH3-like region of the E
protein, it would require that the C-terminal part of the pro-
tein is exposed to the cytoplasm [32]. The C-terminal tail of
the IBV E protein is important for its interaction with the M
protein during virus budding [5]. It is therefore likely that
the NcytoCcyto form of the E protein may be the form that
accomplishes these functions.
In the limited proteinase digestion assay, a proteinase K-
resistant fragment of PDI was consistently observed. The same
fragment as well as some smaller fragments was observed when
PDI expressed in E. coli was treated with proteinase K [12],
conﬁrming that it represents a proteinase K-resistant fragment
of PDI. The smaller fragments were not detected in this study
may be due to fact that the antibody used was raised against
the middle region of PDI from amino acids 211 to 370 only.
Most coronavirus E proteins could be translocated to the
cell surface to facilitate budding and release of progeny viruses
[16,17,19,27]. Recently, the E protein of SARS-CoV and MHV
was found to modify membrane permeability, allowing entry
of small molecules into cells and leading to cell lysis
[14,15,18,31]. As cell surface expression of E protein would
be essential for this function, it is quite certain that SARS-
CoV must be translocated to the cell surface. In this study,
however, we were unable to detect eﬃciently cell surface
expression of the SARS-CoV E protein in cells expressing
the protein under non-permeabilizing conditions. This would
be an additional line of evidence that indirectly supports the
conclusion that the majority of the SARS-CoV E protein
adopts an NcytoCcyto topology in cells. Interestingly, a few ﬂuo-
rescent dots were consistently observed in non-permeabilized
cells expressing the protein. We are currently unclear if these
represent the minor proportion of the SARS-CoV E protein
that expresses on the cell surface and with both N- and C-ter-
mini located outside the cells.
Two of the three coronavirus membrane-associated struc-
tural proteins, M and S, are posttranslationally modiﬁed by
either N- or O-linked glycosylation [23]. The fourth mem-
brane-associated structural protein, the hemagglutinin-esterase
(HE), in some coronaviruses is also a glycoprotein [23]. So far,
the E protein is an apparent exception. In this study, we show
that the SARS-CoV E protein is also modiﬁed by N-linked gly-
cosylation. In N-linked glycosylation, the oligosaccharides are
added to speciﬁc asparagine residues in the consensus sequenceAsn-X-Ser/Thr. The minimum distance between a functional
C-terminal glycosylation acceptor site and the luminal end of
the transmembrane domain is 12–13 residues [24], suggesting
that only the most C-proximal asparagine residue out of the
two potential sites in the SARS-CoV E protein can be glycos-
ylated. Consistent with this observation, mutagenesis studies
present in this paper conﬁrmed that only N66 is modiﬁed. Fur-
thermore, we also show that a potential N-linked glycosylation
site in the N-terminal region of the IBV E protein (N6), which
is 6 amino acids upstream of the transmembrane domain, was
not modiﬁed, although the N-terminal region of this protein is
exposed to the luminal side of the membranes.
N-linked glycosylation aﬀects most of the proteins present on
the surface of the enveloped viruses. For this reason, it is likely
to play a major role in the stability, antigenicity and other bio-
logical functions of the modiﬁed viral envelope proteins. In the
early secretory pathway, the glycans also play a role in protein
folding, quality control and certain sorting events. However, N-
linked glycosylation seems not to aﬀect the membrane-associa-
tion and membrane-permeabilizing activity of the SARS-CoV
E protein. To further characterize the functional signiﬁcance
of this modiﬁcation, it would be interesting to test if N-linked
glycosylation of SARS-CoV E protein can also be detected in
virus-infected cells and in puriﬁed virions. As the N66 residue
is not conserved in the E protein of other coronaviruses, it is
likely that this modiﬁcation may render unique features to
the SARS-CoV E protein. Further exploration of the functions
and eﬀects of this modiﬁcation on SARS-CoV E protein using
an infectious cloning system may shed new light on the molec-
ular biology and pathogenesis of SARS-CoV.
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